ENSC - CIK 0001716947
Ensysce Biosciences, Inc. has filed 529 documents with the SEC between 2017 and 2026. The most frequent type is major company event (119 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2022-05-17 | 2022-05-17 |
| Quarterly report | 10-Q | 2022-05-12 | 2022-03-31 |
| Major company event | 8-K | 2022-05-12 | 2022-05-12 |
| Proxy materials | DEFA14A | 2022-05-06 | - |
| Major company event | 8-K | 2022-05-05 | 2022-05-05 |
| New insider ownership | 3 | 2022-05-04 | 2022-04-18 |
| Proxy materials | DEFA14A | 2022-05-02 | - |
| Proxy statement | DEF 14A | 2022-05-02 | 2022-05-02 |
| Major company event | 8-K | 2022-03-31 | 2022-03-31 |
| Annual report | 10-K | 2022-03-31 | 2021-12-31 |
| Insider trade | 4 | 2022-02-24 | 2022-02-17 |
| Insider trade | 4 | 2022-02-24 | 2022-02-17 |
| Insider trade | 4 | 2022-02-24 | 2022-02-17 |
| New insider ownership | 3 | 2022-02-15 | 2022-02-08 |
| Passive ownership stake (update) | SC 13G/A | 2022-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2022-02-14 | - |
| New insider ownership | 3 | 2022-02-09 | 2021-10-15 |
| Major company event | 8-K | 2022-02-08 | 2022-02-08 |
| Insider trade | 4 | 2022-02-04 | 2022-02-04 |
| Insider trade | 4 | 2022-02-04 | 2022-02-04 |
| Insider trade | 4 | 2022-02-04 | 2022-02-04 |
| Insider trade | 4 | 2022-02-04 | 2022-02-04 |
| Insider trade | 4 | 2022-02-04 | 2022-02-04 |
| Insider trade | 4 | 2022-02-04 | 2022-02-04 |
| Insider trade | 4 | 2022-02-04 | 2022-02-04 |
| Insider trade | 4 | 2022-02-04 | 2022-02-04 |
| Employee stock plan | S-8 | 2022-01-31 | - |
| Major company event | 8-K | 2022-01-27 | 2022-01-27 |
| Proxy materials | DEFA14A | 2022-01-18 | - |
| 424B3 | - | 2022-01-18 | - |
| 424B3 | - | 2022-01-18 | - |
| Major company event | 8-K | 2022-01-18 | 2022-01-18 |
| 424B3 | - | 2021-12-27 | - |
| 424B3 | - | 2021-12-27 | - |
| Proxy materials | DEFA14A | 2021-12-27 | - |
| Major company event | 8-K | 2021-12-27 | 2021-12-27 |
| Proxy materials | DEFA14A | 2021-12-17 | - |
| Proxy statement | DEF 14A | 2021-12-17 | 2021-12-17 |
| PRE 14A | - | 2021-12-01 | 2021-12-01 |
| Major company event | 8-K | 2021-11-16 | 2021-11-16 |
| 424B3 | - | 2021-11-16 | - |
| 424B3 | - | 2021-11-16 | - |
| 424B3 | - | 2021-11-16 | - |
| 424B3 | - | 2021-11-16 | - |
| Quarterly report | 10-Q | 2021-11-15 | 2021-09-30 |
| Major company event | 8-K | 2021-11-10 | 2021-11-10 |
| 424B3 | - | 2021-11-04 | - |
| EFFECT | - | 2021-11-03 | - |
| Company correspondence | CORRESP | 2021-11-01 | - |
| S-1/A | - | 2021-10-29 | - |